The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

Politics

Former Biden doctor asks to delay testimony to House committee investigating mental fitness

by admin July 8, 2025
July 8, 2025
Former Biden doctor asks to delay testimony to House committee investigating mental fitness

Former White House physician Kevin O’Connor, who served as doctor to former President Joe Biden, requested a delay to his upcoming testimony before the House Oversight Committee this week.

O’Connor was scheduled to testify on Wednesday, but is now in a disagreement with the committee over the scope of the questions he will be expected to answer during his testimony. The committee, led by Chairman James Comer, R-Ky., is interviewing the doctor as part of its investigation into Biden’s mental fitness and his administration’s use of an autopen.

A lawyer for O’Connor requested the testimony be delayed to July 28 or August 4 in a letter to Comer.

‘Dr. O’Connor has legal and ethical obligations that he must satisfy and for which violations carry serious consequences to him professionally and personally,’ the letter says.

‘We are unaware of any prior occasion on which a Congressional Committee has subpoenaed a physician to testify about the treatment of an individual patient.  And the notion that a Congressional Committee would do so without any regard whatsoever for the confidentiality of the physician-patient relationship is alarming.’

A spokesman for the Oversight Committee replied in a statement that O’Connor and his legal team were merely trying to ‘stonewall’ the process. The committee is planning to move forward with Wednesday’s testimony, which O’Connor faces a subpoena to attend.

The committee said O’Connor is welcome to object to individual questions during his testimony. But O’Connor is not allowed, in the committee’s view, to delay or decline a congressional subpoena due to concerns over questions about potentially privileged information.

The debate over O’Connor’s testimony comes weeks after a former top aide to Biden, Neera Tanden, told the Oversight Committee that she was authorized to direct autopen signatures but was unaware of who in the president’s inner circle was giving her final clearance.

During Tanden’s interview before Congress last month, which lasted more than five hours, she told lawmakers that, in her role as staff secretary and senior advisor to the former president between 2021 and 2023, she was authorized to direct autopen signatures on behalf of Biden, an Oversight Committee official told Fox News.

‘Ms. Tanden testified that she had minimal interaction with President Biden, despite wielding tremendous authority,’ Comer said at the time. ‘She explained that to obtain approval for autopen signatures, she would send decision memos to members of the President’s inner circle and had no visibility of what occurred between sending the memo and receiving it back with approval. Her testimony raises serious questions about who was really calling the shots in the Biden White House amid the President’s obvious decline. We will continue to pursue the truth for the American people.’

Fox News’ Kelly Phares and Madeleine Rivera and the Associated Press contributed to this report.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Is a Chinese chain’s blood orange cold brew the future of coffee in America?
next post
Key advisor called Hunter Biden’s role on strategy call ‘inappropriate’ after he overruled legal guidance

Related Posts

Maduro trapped with few retaliation options after Trump...

December 14, 2025

Trump says US will send Patriot missiles to...

July 14, 2025

I helped Biden defend against national security threats....

April 10, 2025

Dan Bongino to resign from FBI deputy director...

December 18, 2025

Hillary Clinton blasts Trump’s legal woes amid ‘lock...

August 20, 2024

Trump: China calling ‘a lot’ since last week’s...

April 18, 2025

US and Russia draft peace plan for Ukraine...

November 21, 2025

Senate Republicans look to sweeten Medicaid pot to...

June 26, 2025

Vance says Russia’s demands are too high, but...

May 8, 2025

Get to know Donald Trump’s Cabinet: Who has...

November 24, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • The Real Drivers of This Market: AI, Semis & Robotics

      January 20, 2026
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      January 20, 2026
    • Trump invites Putin, Lukashenko to join Gaza ‘Board of Peace,’ Russia and Belarus say

      January 20, 2026
    • Iran locks nation into ‘darker’ digital blackout, viewing internet as an ‘existential threat’

      January 20, 2026
    • From Caracas to Chicago: Trump’s Article II powers face their biggest tests yet

      January 20, 2026
    • Denmark ramps up defenses in Greenland as Trump zeros in on control of territory

      January 20, 2026

    Categories

    • Business (1,446)
    • Politics (5,566)
    • Stocks (1,903)
    • Uncategorized (45)
    • World News (1,439)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved